in vivo assessment
Recently Published Documents


TOTAL DOCUMENTS

1423
(FIVE YEARS 276)

H-INDEX

67
(FIVE YEARS 8)

2022 ◽  
Vol 5 (1) ◽  
Author(s):  
Emine Can ◽  
Jessica A. M. Bastiaansen ◽  
Dominique-Laurent Couturier ◽  
Rolf Gruetter ◽  
Hikari A. I. Yoshihara ◽  
...  

AbstractHyperpolarized [1-13C]pyruvate enables direct in vivo assessment of real-time liver enzymatic activities by 13C magnetic resonance. However, the technique usually requires the injection of a highly supraphysiological dose of pyruvate. We herein demonstrate that liver metabolism can be measured in vivo with hyperpolarized [1-13C]pyruvate administered at two- to three-fold the basal plasma concentration. The flux through pyruvate dehydrogenase, assessed by 13C-labeling of bicarbonate in the fed condition, was found to be saturated or partially inhibited by supraphysiological doses of hyperpolarized [1-13C]pyruvate. The [13C]bicarbonate signal detected in the liver of fasted rats nearly vanished after treatment with a phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, indicating that the signal originates from the flux through PEPCK. In addition, the normalized [13C]bicarbonate signal in fasted untreated animals is dose independent across a 10-fold range, highlighting that PEPCK and pyruvate carboxylase are not saturated and that hepatic gluconeogenesis can be directly probed in vivo with hyperpolarized [1-13C]pyruvate.


2021 ◽  
Vol 14 (12) ◽  
pp. 1305
Author(s):  
Mohamed A. A. Orabi ◽  
Heba M. A. Khalil ◽  
Mohamed E. Abouelela ◽  
Dalia Zaafar ◽  
Yasmine H. Ahmed ◽  
...  

Chemotherapeutic-related toxicity exacerbates the increasing death rate among cancer patients, necessitating greater efforts to find a speedy solution. An in vivo assessment of the protective effect of the C. macrocarpa leaves polar fraction of hydromethanolic extract against doxorubicin (Dox)-induced neurotoxicity was performed. Intriguingly, this fraction ameliorated Dox-induced cognitive dysfunction; reduced serum ROS and brain TNF-α levels, upregulated the brain nerve growth factor (NGF) levels, markedly reduced caspase-3 immunoexpression, and restored the histological architecture of the brain hippocampus. The in vivo study results were corroborated with a UPLC-ESI-MS/MS profiling that revealed the presence of a high percentage of the plant polyphenolics. Molecular modeling of several identified molecules in this fraction demonstrated a strong binding affinity of flavan-3-ol derivatives with TACE enzymes, in agreement with the experimental in vivo neuroprotective activity. In conclusion, the C. macrocarpa leaves polar fraction possesses neuroprotective activity that could have a promising role in ameliorating chemotherapeutic-induced side effects.


Author(s):  
Lorrane Davi Brito ◽  
Caroline de Souza Araujo ◽  
Dalita Gomes Silva Moraes Cavalcante ◽  
Andressa Silva Gomes ◽  
Marcos Alberto Zocoler ◽  
...  

Author(s):  
Keishi Yamasaki ◽  
Masahiro Fujisaki-Hirakawa ◽  
Kazuaki Taguchi ◽  
Daisuke Kadowaki ◽  
Kenji Tsukigawa ◽  
...  

Author(s):  
Ding Li ◽  
Dechuang Zhang ◽  
Qi Yuan ◽  
Lihong Liu ◽  
Hui Li ◽  
...  

Nanomaterials ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 3152
Author(s):  
Afrah Nawaz ◽  
Syed Mohsin Ali ◽  
Nosheen Fatima Rana ◽  
Tahreem Tanweer ◽  
Amna Batool ◽  
...  

Metallic nanoparticles, such as gold nanoparticles (AuNPs), have been extensively studied as drug delivery systems for various therapeutic applications. However, drug-loaded-AuNPs have been rarely explored in vivo for their effect on bacteria residing inside tissues. Ciprofloxacin (CIP) is a second-generation fluoroquinolone with a broad-spectrum of antibiotic properties devoid of developing bacteria resistance. This research is focused on the synthesis and physical characterization of Ciprofloxacin-loaded gold nanoparticles (CIP-AuNPs) and their effect on the colonization of Enterococcus faecalis in the liver and kidneys of mice. The successfully prepared CIP-AuNPs were stable and exerted enhanced in vitro antibacterial activity against E. faecalis compared with free CIP. The optimized CIP-AuNPs were administered (500 µg/Kg) once a day via tail vein to infected mice for eight days and were found to be effective in eradicating E. faecalis from the host tissues. Moreover, unlike CIP, CIP-AuNPs were non-hemolytic. In summary, this study demonstrated that CIP-AuNPs are promising and biocompatible alternative therapeutics for E.-faecalis-induced infections resistant to conventional drugs (e.g., beta-lactams and vancomycin) and should be further investigated.


Author(s):  
Weizhi Xu ◽  
Faheem Maqbool ◽  
Vinod Kumar ◽  
James R. Falconer ◽  
Cedric S. Cui ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document